Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2007; 13(48): 6593-6597
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6593
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6593
Table 3 Follow-up results of PLT counts (× 109/L)
Time | Group A | Group B | P-value2 | ||
mean ± SD | P-value1 | mean ± SD | P-value1 | ||
Pre-treatment | 45.95 ± 9.49 | 45.02 ± 8.96 | 0.723 | ||
Post-treatment | |||||
1 wk | 169.21 ± 26.55 | < 0.001 | 28.56 ± 5.11 | < 0.001 | < 0.001 |
2 wk | 136.50 ± 13.12 | < 0.001 | 26.62 ± 7.31 | < 0.001 | < 0.001 |
1 mo | 133.46 ± 16.21 | < 0.001 | 27.46 ± 6.29 | < 0.001 | < 0.001 |
2 mo | 125.73 ± 18.35 | < 0.001 | 31.06 ± 6.70 | < 0.001 | < 0.001 |
3 mo | 119.86 ± 12.43 | < 0.001 | 33.15 ± 6.91 | < 0.001 | < 0.001 |
- Citation: Huang JH, Gao F, Gu YK, Li WQ, Lu LW. Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization. World J Gastroenterol 2007; 13(48): 6593-6597
- URL: https://www.wjgnet.com/1007-9327/full/v13/i48/6593.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i48.6593